Sensitivity of Urinary Mesothelin in Patients with Malignant Mesothelioma
Authors:
Open Access
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (9) , 1461-1466
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western AustraliaJournal of Thoracic Oncology, 2009
- Glomerular Filtration Rate Is a Confounder for the Measurement of Soluble Mesothelin in SerumClinical Chemistry, 2009
- Urothelial bladder cancer: biomarkers for detection and screeningBJU International, 2008
- Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant MesotheliomaChest, 2007
- Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragmentGynecologic Oncology, 2007
- Mesothelin Variant 1 Is Released from Tumor Cells as a Diagnostic MarkerCancer Epidemiology, Biomarkers & Prevention, 2006
- Advances in Malignant MesotheliomaNew England Journal of Medicine, 2005
- MesothelinClinical Cancer Research, 2004
- Molecular Cloning and Expression of Megakaryocyte Potentiating Factor cDNAJournal of Biological Chemistry, 1995
- Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusionsInternational Journal of Cancer, 1991